Showing results (1-10 of 1,079) with videos related to

Sort By:
Pageof 108
Arzneimittel-Forschung|January 1, 1980
Glycosaminoglycans from pig duodenumB Casu, M Moretti, P Oreste, et al.
Seminars in Thrombosis and Hemostasis|November 5, 1999
Structural characterization of low molecular weight heparinsB Casu, G Torri
Seminars in Thrombosis and Hemostasis|October 23, 2001
Toward a biotechnological heparin through combined chemical and enzymatic modification of the Escherichia coli K5 polysaccharideA Naggi, G Torri, B Casu, et al.
Arzneimittel-Forschung|January 1, 1980
Absorption by the rat intestinal tract of fluorescein-labelled pig duodenal glycosaminoglycansR Pescador, G Diamantini, M Mantovani, et al.
The Biochemical Journal|September 1, 1981
The structure of heparin oligosaccharide fragments with high anti-(factor Xa) activity containing the minimal antithrombin III-binding sequence. Chemical and 13C nuclear-magnetic-resonance studiesB Casu, P Oreste, G Torri, et al.
Arzneimittel-Forschung|January 1, 1983
Correlation between structure, fat-clearing and anticoagulant properties of heparins and heparan sulphatesB Casu, E A Johnson, M Mantovani, et al.
Arzneimittel-Forschung|April 1, 1986
Retention of antilipemic activity by periodate-oxidized non-anticoagulant heparinsB Casu, G Diamantini, G Fedeli, et al.
Carbohydrate Research|October 17, 1994
Heparin-like compounds prepared by chemical modification of capsular polysaccharide from E. coli K5B Casu, G Grazioli, N Razi, et al.
The Journal of Biological Chemistry|May 5, 1990
Biosynthesis of heparin. Availability of glucosaminyl 3-O-sulfation sitesM Kusche, G Torri, B Casu, et al.
Carbohydrate Research|May 9, 1997
Motional properties of E. coli polysaccharide K5 in aqueous solution analyzed by NMR relaxation measurementsM Hricovíni, M Guerrini, G Torri, et al.
Pageof 108